c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner.
Tolerance to the antinociceptive effects of cannabinoids represents a significant limitation to their clinical use in managing chronic pain. Tolerance likely results from desensitization and down-regulation of the cannabinoid type 1 receptor (CB